Does SAVOLITINIB Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with SAVOLITINIB. This represents 6.9% of all adverse event reports for SAVOLITINIB.
5
Reports of Malignant neoplasm progression with SAVOLITINIB
6.9%
of all SAVOLITINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SAVOLITINIB?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SAVOLITINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SAVOLITINIB Cause?
Hepatic function abnormal (10)
Drug-induced liver injury (9)
Pyrexia (9)
Alanine aminotransferase increased (5)
Aspartate aminotransferase increased (5)
Drug resistance (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)